Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;172(9):1173-80.
doi: 10.1007/s00431-013-2016-5. Epub 2013 May 5.

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates

Affiliations

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates

J K Trittmann et al. Eur J Pediatr. 2013 Sep.

Abstract

We tested the hypothesis that the use of supplemental oxygen (sO2) at discharge from the NICU in extremely preterm neonates is associated with a greater risk of neurodevelopmental impairment (NDI) at 18 months corrected gestational age (CGA) than the risk of NDI of those neonates discharged in room air. Four hundred twenty-four charts were retrospectively reviewed from infants born at <27 weeks and transferred to Nationwide Children's Hospital from December 1, 2004 to June 14, 2010. Use of sO2 was evaluated on day of life (dol) 28, at 36 weeks post-menstrual age (PMA), and at discharge. Logistic regression was used to identify postnatal risk factors associated with sO2 at discharge and NDI. At dol 28, 96 % of surviving patients received sO2, and therefore had bronchopulmonary dysplasia (BPD) by definition from a National Institutes of Child Health and Human Development workshop. At 36 weeks PMA, 89 % continued on sO2 (moderate/severe BPD), and at discharge, 74 % continued on sO2. When factors associated with NDI were examined, the need for mechanical ventilation ≥28 days (adjOR = 3.21, p = 0.01), grade III-IV intraventricular hemorrhage (IVH) (adjOR = 4.61, p < 0.01), and discharge at >43 weeks PMA (adjOR = 2.12, p = 0.04) were the strongest predictors of NDI at 18 months CGA. There was no difference in Bayley Scales of Infant Development, third edition composite scores between patients with no/mild BPD and patients with moderate/severe BPD (cognitive p = 0.60, communication p = 0.53, motor p = 0.19) or those scores between patients on and off oxygen at discharge (cognitive p = 0.58, communication p = 0.70, motor p = 0.62).

Conclusions: The need for sO2 at discharge is not associated with an increased risk of NDI in these patients. The strongest predictors of poor neurodevelopmental outcome in this population were prolonged positive pressure support, grade III-IV IVH, and discharge at >43 weeks PMA.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Patients admitted between December 1, 2004 and June 14, 2010. Three hundred forty-five patients born at <27 weeks gestation were eligible for this study on day of life (dol) 28. At discharge, there remained 276 patients of which 2 % died and 15 % did not return for follow-up at the neonatal clinic. At 18 months corrected gestational age, 30 patients had cerebral palsy (CP) and 201 patients had Bayley scores available for analysis
Fig. 2
Fig. 2
BSID-III composite scores (cognitive, communication, and motor) of neonates born at <27weeks gestation (n = 201). Boxplots represent median and interquartile range. a Boxplots comparing no/mild BPD to those neonates with moderate/severe BPD. Student’s t test for cognitive score (p = 0.60), communication score (p = 0.53), and motor score (p = 0.19). There was no significant difference (ns) between the no/mild BPD and moderate/severe BPD groups. b Boxplots comparing no supplemental oxygen (sO 2) at discharge to those neonates receiving sO2 at discharge. Student's t test for cognitive score (p = 0.58), communication score (p = 0.70), and motor score (p = 0.62). There was no significant difference (ns) between the no sO2 at discharge and sO2 at discharge groups

References

    1. American Academy of Pediatrics Committee on Fetus and Newborn Levels of neonatal care. Pediatrics. 2012;130:587–597. doi: 10.1542/peds.2012-1999. - DOI - PubMed
    1. Anderson PJ, De Luca CR, Hutchinson E, Roberts G, Doyle LW. Underestimation of developmental delay by the new Bayley-III scale. Arch Pediatr Adolesc Med. 2010;164:352–356. doi: 10.1001/archpediatrics.2010.20. - DOI - PubMed
    1. Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:227–232. doi: 10.1053/j.semperi.2006.05.010. - DOI - PubMed
    1. Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol. 2006;30:164–170. doi: 10.1053/j.semperi.2006.05.002. - DOI - PubMed
    1. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 2003;8:63–71. doi: 10.1016/S1084-2756(02)00192-6. - DOI - PubMed

MeSH terms